Vir Biotechnology Achieves Target Enrollment for Groundbreaking Phase 2 PENINSULA Trial Evaluating VIR-2482 for Prevention of Seasonal Influenza A
December 21, 2022 08:00 ET
|
Vir Biotechnology, Inc.
SAN FRANCISCO, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced it has achieved the target enrollment of approximately 3,000 participants in the groundbreaking...
Luxury Institute Survey: High Net-Worth Consumers Rank "Best of the Best" Luxury Hotel Brands
April 23, 2009 07:00 ET
|
The Luxury Institute
NEW YORK, NY--(Marketwire - April 23, 2009) - The Luxury Institute reported today
the top-rated luxury hotel brands in the 2009 Luxury Brand
Status Index (LBSI) survey, which identifies the top...